CompletedPhase 2NCT02918292
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Studying Aplastic Anemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical College of Wisconsin
- Principal Investigator
- Mary Horowitz, MD, MSCenter for International Blood and Marrow Transplant Research
- Intervention
- Antithymocyte Globulin (ATG)(drug)
- Enrollment
- 32 enrolled
- Eligibility
- 75 years · All sexes
- Timeline
- 2017 – 2021
Study locations (28)
- City of Hope National Medical Center, Duarte, California, United States
- Children's Hospital of Los Angeles, Los Angeles, California, United States
- Children's Hospital and Research Center Oakland, Oakland, California, United States
- Stanford Hospital and Clinics, Stanford, California, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- University of Florida College of Medicine, Gainesville, Florida, United States
- Miami Children's Hospital, Miami, Florida, United States
- All Children's Hospital, St. Petersburg, Florida, United States
- H. Lee Moffitt Cancer Center, Tampa, Florida, United States
- Northside Hospital, Atlanta, Georgia, United States
- Indiana University Medical Center/ Riley Hospital for Children, Indianapolis, Indiana, United States
- University of Louisville/Kosair Children's Hospital, Louisville, Kentucky, United States
- Johns Hopkins Unversity, Baltimore, Maryland, United States
- University of Michigan Medical Center, Ann Arbor, Michigan, United States
- Karmanos Cancer Institute/Children's Hospital of Michigan, Detroit, Michigan, United States
- +13 more locations on ClinicalTrials.gov
Collaborators
National Heart, Lung, and Blood Institute (NHLBI) · National Cancer Institute (NCI) · Blood and Marrow Transplant Clinical Trials Network · National Marrow Donor Program
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02918292 on ClinicalTrials.govOther trials for Aplastic Anemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07461116Adverse Effects of ATG/ALG Therapy in Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE2NCT07400341Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AAThe First Affiliated Hospital of Soochow University
- RECRUITINGNANCT07101770A Prediction Model in Pregnant Women With Aplastic AnemiaPeking University People's Hospital
- RECRUITINGNANCT07499284A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic AnemiaThe First Affiliated Hospital of Soochow University
- RECRUITINGPHASE2NCT06752694Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic AnemiaFred Hutchinson Cancer Center
- RECRUITINGPHASE1NCT06622694CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE2NCT06517641Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic AnemiaMedical College of Wisconsin
- RECRUITINGNANCT06936930Reproductive and Mental Health of Patients With Aplastic AnemiaInstitute of Hematology & Blood Diseases Hospital, China